Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jayne, DR, Rasmussen, N
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	1997

Míreanna comhchosúla

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
de réir: Mukhtyar, C, et al.
Foilsithe / Cruthaithe: (2006)

Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
de réir: Rohini Handa
Foilsithe / Cruthaithe: (2018-01-01)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
de réir: John Chuan Nguyen Tran, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
de réir: Flossmann, O, et al.
Foilsithe / Cruthaithe: (2006)

Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
de réir: Brendan L. Thoms, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
de réir: Mukhtyar, C, et al.
Foilsithe / Cruthaithe: (2008)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
de réir: De Groot, K, et al.
Foilsithe / Cruthaithe: (2005)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
de réir: T V Beketova
Foilsithe / Cruthaithe: (2018-05-01)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
de réir: Lauren Floyd, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
de réir: E. N. Vorkel, et al.
Foilsithe / Cruthaithe: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
de réir: E. N. Vorkel, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
de réir: Megan M. Sullivan, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Complement blockade in the management of antineutrophil cytoplasmic antibodyassociated vasculitis
de réir: JosÃ© Salvador GarcÃa-Morillo, et al.
Foilsithe / Cruthaithe: (2022-10-01)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
de réir: Rajaie Namas, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
de réir: Tian-Tian Ma, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
de réir: Mukhtyar, C, et al.
Foilsithe / Cruthaithe: (2008)

Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan
de réir: Genri Tagami, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
de réir: Morishita, K, et al.
Foilsithe / Cruthaithe: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
de réir: Saket Jha, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
de réir: Katarzyna Wawrzycka-Adamczyk, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
de réir: Deep Shikha, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
de réir: Sunil Kapur, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
de réir: Durga Prasanna Misra, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
de réir: Weiwei Hao, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
de réir: Noah Huizenga, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
de réir: Weiran Li, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
de réir: Yoon Kook Kim, MD, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
de réir: Rui-Xue Wang, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
de réir: Taejun Yoon, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
de réir: Sourabh Chand, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
de réir: Walsh, M, et al.
Foilsithe / Cruthaithe: (2011)

Arthritis as a clinical manifestation of antineutrophil cytoplasmic antibody-associated systemic vasculitis: diagnostic difficulties
de réir: T. V. Beketova, et al.
Foilsithe / Cruthaithe: (2018-06-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
de réir: Talks, S, et al.
Foilsithe / Cruthaithe: (1994)

Antineutrophil Cytoplasmic Antibody Vasculitis after Coronary Artery Bypass Grafting
de réir: Dwight D. Harris, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
de réir: B N Shiva Prasad, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
de réir: O. N. Egorova, et al.
Foilsithe / Cruthaithe: (2024-10-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
de réir: Kunal Chandwar, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
de réir: Zdenka Hruskova, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Antineutrophil cytoplasmic antibody vasculitis causing skull base inflammation and aortitis
de réir: Boby Varkey Maramattom, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
de réir: Jamie R. Felzer, et al.
Foilsithe / Cruthaithe: (2022-01-01)